Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 80 entries
Sorted by: Best Match Show Resources per page
Data and analysis script for infant and adult eye movement in an adapted ocular-motor serial reaction time task assessing procedural memory.

Data in brief

Koch FS, Sundqvist A, Thornberg UB, Ullman MT, Barr R, Rudner M, Heimann M.
PMID: 31993467
Data Brief. 2020 Jan 08;29:105108. doi: 10.1016/j.dib.2020.105108. eCollection 2020 Apr.

This article provides a description of eye movement data collected during an ocular-motor serial reaction time task. Raw gaze data files for 63 infants and 24 adults along with the data processing and analysis script for extracting saccade latencies,...

Cite
Koch FS, Sundqvist A, Thornberg UB, et al. Data and analysis script for infant and adult eye movement in an adapted ocular-motor serial reaction time task assessing procedural memory. Data Brief. 2020;29:105108doi: 10.1016/j.dib.2020.105108.
Koch, F. S., Sundqvist, A., Thornberg, U. B., Ullman, M. T., Barr, R., Rudner, M., & Heimann, M. (2020). Data and analysis script for infant and adult eye movement in an adapted ocular-motor serial reaction time task assessing procedural memory. Data in brief, 29105108. https://doi.org/10.1016/j.dib.2020.105108
Koch, Felix-Sebastian, et al. "Data and analysis script for infant and adult eye movement in an adapted ocular-motor serial reaction time task assessing procedural memory." Data in brief vol. 29 (2020): 105108. doi: https://doi.org/10.1016/j.dib.2020.105108
Koch FS, Sundqvist A, Thornberg UB, Ullman MT, Barr R, Rudner M, Heimann M. Data and analysis script for infant and adult eye movement in an adapted ocular-motor serial reaction time task assessing procedural memory. Data Brief. 2020 Jan 08;29:105108. doi: 10.1016/j.dib.2020.105108. eCollection 2020 Apr. PMID: 31993467; PMCID: PMC6971346.
Copy Download .nbib Format: NLM
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

JAMA internal medicine

Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, Fry AM, Cannon DL, Chiang CF, Gibbons A, Krapiunaya I, Morales-Betoulle M, Roguski K, Rasheed MAU, Freeman B, Lester S, Mills L, Carroll DS, Owen SM, Johnson JA, Semenova V, Blackmore C, Blog D, Chai SJ, Dunn A, Hand J, Jain S, Lindquist S, Lynfield R, Pritchard S, Sokol T, Sosa L, Turabelidze G, Watkins SM, Wiesman J, Williams RW, Yendell S, Schiffer J, Thornburg NJ.
PMID: 32692365
JAMA Intern Med. 2020 Jul 21; doi: 10.1001/jamainternmed.2020.4130. Epub 2020 Jul 21.

IMPORTANCE: Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimate the prevalence of infection in affected communities. Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected.OBJECTIVE: To estimate prevalence of...

Cite
Havers FP, Reed C, Lim T, et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020;doi: 10.1001/jamainternmed.2020.4130.
Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., Fry, A. M., Cannon, D. L., Chiang, C. F., Gibbons, A., Krapiunaya, I., Morales-Betoulle, M., Roguski, K., Rasheed, M. A. U., Freeman, B., Lester, S., Mills, L., Carroll, D. S., Owen, S. M., Johnson, J. A., Semenova, V., Blackmore, C., Blog, D., Chai, S. J., Dunn, A., Hand, J., Jain, S., Lindquist, S., Lynfield, R., Pritchard, S., Sokol, T., Sosa, L., Turabelidze, G., Watkins, S. M., Wiesman, J., Williams, R. W., Yendell, S., Schiffer, J., & Thornburg, N. J. (2020). Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA internal medicine, . https://doi.org/10.1001/jamainternmed.2020.4130
Havers, Fiona P, et al. "Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020." JAMA internal medicine vol. (2020). doi: https://doi.org/10.1001/jamainternmed.2020.4130
Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, Fry AM, Cannon DL, Chiang CF, Gibbons A, Krapiunaya I, Morales-Betoulle M, Roguski K, Rasheed MAU, Freeman B, Lester S, Mills L, Carroll DS, Owen SM, Johnson JA, Semenova V, Blackmore C, Blog D, Chai SJ, Dunn A, Hand J, Jain S, Lindquist S, Lynfield R, Pritchard S, Sokol T, Sosa L, Turabelidze G, Watkins SM, Wiesman J, Williams RW, Yendell S, Schiffer J, Thornburg NJ. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21; doi: 10.1001/jamainternmed.2020.4130. Epub 2020 Jul 21. PMID: 32692365.
Copy Download .nbib Format: NLM
Descriptive Evaluation of Antibody Responses to SARS-CoV-2 Infection in Plasma and Gingival Crevicular Fluid in a Nursing Home Cohort-Arkansas, June-August 2020.

Infection control and hospital epidemiology

Brown NE, Lyons AK, Schuh AJ, Stumpf MM, Harcourt JL, Tamin A, Rasheed MAU, Mills L, Lester SN, Thornburg NJ, Nguyen K, Costantini V, Vinjé J, Huang JY, Gilbert SE, Gable P, Bollinger S, Sabour S, Beshearse E, Surie D, Biedron C, Gregory CJ, Clemmons NS, Whitaker B, Coughlin MM, Seely KA, Garner K, Gulley T, Haney T, Kothari A, Patil N, Halpin AL, McDonald LC, Kutty PK, Brown AC.
PMID: 34802478
Infect Control Hosp Epidemiol. 2021 Nov 22;1-24. doi: 10.1017/ice.2021.484. Epub 2021 Nov 22.

OBJECTIVE: Characterize and compare SARS-CoV-2-specific immune responses in plasma and gingival crevicular fluid (GCF) from nursing home residents during and after natural infection.DESIGN: Prospective cohort.SETTING: Nursing home.PARTICIPANTS: SARS-CoV-2-infected nursing home residents.METHODS: A convenience sample of 14 SARS-CoV-2-infected nursing home...

Cite
Brown NE, Lyons AK, Schuh AJ, et al. Descriptive Evaluation of Antibody Responses to SARS-CoV-2 Infection in Plasma and Gingival Crevicular Fluid in a Nursing Home Cohort-Arkansas, June-August 2020. Infect Control Hosp Epidemiol. 2021;1-24doi: 10.1017/ice.2021.484.
Brown, N. E., Lyons, A. K., Schuh, A. J., Stumpf, M. M., Harcourt, J. L., Tamin, A., Rasheed, M. A. U., Mills, L., Lester, S. N., Thornburg, N. J., Nguyen, K., Costantini, V., Vinjé, J., Huang, J. Y., Gilbert, S. E., Gable, P., Bollinger, S., Sabour, S., Beshearse, E., Surie, D., Biedron, C., Gregory, C. J., Clemmons, N. S., Whitaker, B., Coughlin, M. M., Seely, K. A., Garner, K., Gulley, T., Haney, T., Kothari, A., Patil, N., Halpin, A. L., McDonald, L. C., Kutty, P. K., & Brown, A. C. (2021). Descriptive Evaluation of Antibody Responses to SARS-CoV-2 Infection in Plasma and Gingival Crevicular Fluid in a Nursing Home Cohort-Arkansas, June-August 2020. Infection control and hospital epidemiology, 1-24. https://doi.org/10.1017/ice.2021.484
Brown, Nicole E, et al. "Descriptive Evaluation of Antibody Responses to SARS-CoV-2 Infection in Plasma and Gingival Crevicular Fluid in a Nursing Home Cohort-Arkansas, June-August 2020." Infection control and hospital epidemiology vol. (2021): 1-24. doi: https://doi.org/10.1017/ice.2021.484
Brown NE, Lyons AK, Schuh AJ, Stumpf MM, Harcourt JL, Tamin A, Rasheed MAU, Mills L, Lester SN, Thornburg NJ, Nguyen K, Costantini V, Vinjé J, Huang JY, Gilbert SE, Gable P, Bollinger S, Sabour S, Beshearse E, Surie D, Biedron C, Gregory CJ, Clemmons NS, Whitaker B, Coughlin MM, Seely KA, Garner K, Gulley T, Haney T, Kothari A, Patil N, Halpin AL, McDonald LC, Kutty PK, Brown AC. Descriptive Evaluation of Antibody Responses to SARS-CoV-2 Infection in Plasma and Gingival Crevicular Fluid in a Nursing Home Cohort-Arkansas, June-August 2020. Infect Control Hosp Epidemiol. 2021 Nov 22;1-24. doi: 10.1017/ice.2021.484. Epub 2021 Nov 22. PMID: 34802478.
Copy Download .nbib Format: NLM
Downward Spiral of Bullying: Victimization Timeline From Former Victims' Perspective.

Journal of interpersonal violence

Wójcik M, Thornberg R, Flak W, Leśniewski J.
PMID: 33525987
J Interpers Violence. 2021 Feb 01;886260521990835. doi: 10.1177/0886260521990835. Epub 2021 Feb 01.

The present study aimed to investigate how those who had been chronic victims of bullying perceive their bullying experience from their initial attacks to their bullying exit, how they understood processes and actions causing a situation to become progressively...

Cite
Wójcik M, Thornberg R, Flak W, et al. Downward Spiral of Bullying: Victimization Timeline From Former Victims' Perspective. J Interpers Violence. 2021;886260521990835doi: 10.1177/0886260521990835.
Wójcik, M., Thornberg, R., Flak, W., & Leśniewski, J. (2021). Downward Spiral of Bullying: Victimization Timeline From Former Victims' Perspective. Journal of interpersonal violence, 886260521990835. https://doi.org/10.1177/0886260521990835
Wójcik, Małgorzata, et al. "Downward Spiral of Bullying: Victimization Timeline From Former Victims' Perspective." Journal of interpersonal violence vol. (2021): 886260521990835. doi: https://doi.org/10.1177/0886260521990835
Wójcik M, Thornberg R, Flak W, Leśniewski J. Downward Spiral of Bullying: Victimization Timeline From Former Victims' Perspective. J Interpers Violence. 2021 Feb 01;886260521990835. doi: 10.1177/0886260521990835. Epub 2021 Feb 01. PMID: 33525987.
Copy Download .nbib Format: NLM
Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity.

Archives of toxicology

Hengstler JG, Sjögren AK, Zink D, Hornberg JJ.
PMID: 34283277
Arch Toxicol. 2021 Sep;95(9):3141. doi: 10.1007/s00204-021-03090-4.

No abstract available.

Cite
Hengstler JG, Sjögren AK, Zink D, et al. Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity. Arch Toxicol. 2021;95(9):3141doi: 10.1007/s00204-021-03090-4.
Hengstler, J. G., Sjögren, A. K., Zink, D., & Hornberg, J. J. (2021). Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity. Archives of toxicology, 95(9), 3141. https://doi.org/10.1007/s00204-021-03090-4
Hengstler, Jan G, et al. "Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity." Archives of toxicology vol. 95,9 (2021): 3141. doi: https://doi.org/10.1007/s00204-021-03090-4
Hengstler JG, Sjögren AK, Zink D, Hornberg JJ. Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity. Arch Toxicol. 2021 Sep;95(9):3141. doi: 10.1007/s00204-021-03090-4. PMID: 34283277; PMCID: PMC8380232.
Copy Download .nbib Format: NLM
Bystander motivation in bullying incidents: to intervene or not to intervene?.

The western journal of emergency medicine

Thornberg R, Tenenbaum L, Varjas K, Meyers J, Jungert T, Vanegas G.
PMID: 22900122
West J Emerg Med. 2012 Aug;13(3):247-52. doi: 10.5811/westjem.2012.3.11792.

INTRODUCTION: This research sought to extend knowledge about bystanders in bullying situations with a focus on the motivations that lead them to different responses. The 2 primary goals of this study were to investigate the reasons for children's decisions...

Cite
Thornberg R, Tenenbaum L, Varjas K, et al. Bystander motivation in bullying incidents: to intervene or not to intervene?. West J Emerg Med. 2012;13(3):247-52doi: 10.5811/westjem.2012.3.11792.
Thornberg, R., Tenenbaum, L., Varjas, K., Meyers, J., Jungert, T., & Vanegas, G. (2012). Bystander motivation in bullying incidents: to intervene or not to intervene?. The western journal of emergency medicine, 13(3), 247-52. https://doi.org/10.5811/westjem.2012.3.11792
Thornberg, Robert, et al. "Bystander motivation in bullying incidents: to intervene or not to intervene?." The western journal of emergency medicine vol. 13,3 (2012): 247-52. doi: https://doi.org/10.5811/westjem.2012.3.11792
Thornberg R, Tenenbaum L, Varjas K, Meyers J, Jungert T, Vanegas G. Bystander motivation in bullying incidents: to intervene or not to intervene?. West J Emerg Med. 2012 Aug;13(3):247-52. doi: 10.5811/westjem.2012.3.11792. PMID: 22900122; PMCID: PMC3415829.
Copy Download .nbib Format: NLM
Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.

The Journal of infectious diseases

Shragai T, Smith-Jeffcoat SE, Koh M, Schechter MC, Rebolledo PA, Kasinathan V, Wang Y, Hoffman A, Miller H, Tejada-Strop A, Jain S, Tamin A, Harcourt JL, Thornburg NJ, Wong P, Medrzycki M, Folster JM, Semenova V, Steward-Clark E, Drobenuic J, Biedron C, Stewart RJ, da Silva J, Kirking HL, Tate JE.
PMID: 34216468
J Infect Dis. 2021 Jul 03; doi: 10.1093/infdis/jiab349. Epub 2021 Jul 03.

BACKGROUND: The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing.METHODS: Nasopharyngeal swabs and serum were collected at a...

Cite
Shragai T, Smith-Jeffcoat SE, Koh M, et al. Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing. J Infect Dis. 2021;doi: 10.1093/infdis/jiab349.
Shragai, T., Smith-Jeffcoat, S. E., Koh, M., Schechter, M. C., Rebolledo, P. A., Kasinathan, V., Wang, Y., Hoffman, A., Miller, H., Tejada-Strop, A., Jain, S., Tamin, A., Harcourt, J. L., Thornburg, N. J., Wong, P., Medrzycki, M., Folster, J. M., Semenova, V., Steward-Clark, E., Drobenuic, J., Biedron, C., Stewart, R. J., da Silva, J., Kirking, H. L., Tate, J. E. (2021). Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing. The Journal of infectious diseases, . https://doi.org/10.1093/infdis/jiab349
Shragai, Talya, et al. "Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing." The Journal of infectious diseases vol. (2021). doi: https://doi.org/10.1093/infdis/jiab349
Shragai T, Smith-Jeffcoat SE, Koh M, Schechter MC, Rebolledo PA, Kasinathan V, Wang Y, Hoffman A, Miller H, Tejada-Strop A, Jain S, Tamin A, Harcourt JL, Thornburg NJ, Wong P, Medrzycki M, Folster JM, Semenova V, Steward-Clark E, Drobenuic J, Biedron C, Stewart RJ, da Silva J, Kirking HL, Tate JE. Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing. J Infect Dis. 2021 Jul 03; doi: 10.1093/infdis/jiab349. Epub 2021 Jul 03. PMID: 34216468.
Copy Download .nbib Format: NLM
Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents.

Infection control and hospital epidemiology

Moritz ED, McKay SL, Tobolowsky FA, LaVoie SP, Waltenburg MA, Lecy KD, Thornburg NJ, Harcourt JL, Tamin A, Folster JM, Negley J, Brown AC, McDonald LC, Kutty PK.
PMID: 34412728
Infect Control Hosp Epidemiol. 2021 Aug 20;1-4. doi: 10.1017/ice.2021.370. Epub 2021 Aug 20.

Repeated antigen testing of 12 severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents using Abbott BinaxNOW identified 9 of 9 (100%) culture-positive specimens up to 6 days after initial positive test. Antigen positivity lasted 2-24 days. Antigen...

Cite
Moritz ED, McKay SL, Tobolowsky FA, et al. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infect Control Hosp Epidemiol. 2021;1-4doi: 10.1017/ice.2021.370.
Moritz, E. D., McKay, S. L., Tobolowsky, F. A., LaVoie, S. P., Waltenburg, M. A., Lecy, K. D., Thornburg, N. J., Harcourt, J. L., Tamin, A., Folster, J. M., Negley, J., Brown, A. C., McDonald, L. C., Kutty, P. K. (2021). Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infection control and hospital epidemiology, 1-4. https://doi.org/10.1017/ice.2021.370
Moritz, Erin D, et al. "Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents." Infection control and hospital epidemiology vol. (2021): 1-4. doi: https://doi.org/10.1017/ice.2021.370
Moritz ED, McKay SL, Tobolowsky FA, LaVoie SP, Waltenburg MA, Lecy KD, Thornburg NJ, Harcourt JL, Tamin A, Folster JM, Negley J, Brown AC, McDonald LC, Kutty PK. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infect Control Hosp Epidemiol. 2021 Aug 20;1-4. doi: 10.1017/ice.2021.370. Epub 2021 Aug 20. PMID: 34412728.
Copy Download .nbib Format: NLM
Post-nucleation evolution of the liquid-solid interface in nanowire growth.

Nanotechnology

Maliakkal CB, Jacobsson D, Tornberg M, Dick KA.
PMID: 34847548
Nanotechnology. 2021 Dec 17;33(10). doi: 10.1088/1361-6528/ac3e8d.

We study using

Cite
Maliakkal CB, Jacobsson D, Tornberg M, et al. Post-nucleation evolution of the liquid-solid interface in nanowire growth. Nanotechnology. 2021;33(10)doi: 10.1088/1361-6528/ac3e8d.
Maliakkal, C. B., Jacobsson, D., Tornberg, M., & Dick, K. A. (2021). Post-nucleation evolution of the liquid-solid interface in nanowire growth. Nanotechnology, 33(10), . https://doi.org/10.1088/1361-6528/ac3e8d
Maliakkal, Carina B, et al. "Post-nucleation evolution of the liquid-solid interface in nanowire growth." Nanotechnology vol. 33,10 (2021). doi: https://doi.org/10.1088/1361-6528/ac3e8d
Maliakkal CB, Jacobsson D, Tornberg M, Dick KA. Post-nucleation evolution of the liquid-solid interface in nanowire growth. Nanotechnology. 2021 Dec 17;33(10). doi: 10.1088/1361-6528/ac3e8d. PMID: 34847548.
Copy Download .nbib Format: NLM
Kinetics of Au-Ga Droplet Mediated Decomposition of GaAs Nanowires.

Nano letters

Tornberg M, Jacobsson D, Persson AR, Wallenberg R, Dick KA, Kodambaka S.
PMID: 31039317
Nano Lett. 2019 Jun 12;19(6):3498-3504. doi: 10.1021/acs.nanolett.9b00321. Epub 2019 May 09.

Particle-assisted III-V semiconductor nanowire growth and applications thereof have been studied extensively. However, the stability of nanowires in contact with the particle and the particle chemical composition as a function of temperature remain largely unknown. In this work, we...

Cite
Tornberg M, Jacobsson D, Persson AR, et al. Kinetics of Au-Ga Droplet Mediated Decomposition of GaAs Nanowires. Nano Lett. 2019;19(6):3498-3504doi: 10.1021/acs.nanolett.9b00321.
Tornberg, M., Jacobsson, D., Persson, A. R., Wallenberg, R., Dick, K. A., & Kodambaka, S. (2019). Kinetics of Au-Ga Droplet Mediated Decomposition of GaAs Nanowires. Nano letters, 19(6), 3498-3504. https://doi.org/10.1021/acs.nanolett.9b00321
Tornberg, Marcus, et al. "Kinetics of Au-Ga Droplet Mediated Decomposition of GaAs Nanowires." Nano letters vol. 19,6 (2019): 3498-3504. doi: https://doi.org/10.1021/acs.nanolett.9b00321
Tornberg M, Jacobsson D, Persson AR, Wallenberg R, Dick KA, Kodambaka S. Kinetics of Au-Ga Droplet Mediated Decomposition of GaAs Nanowires. Nano Lett. 2019 Jun 12;19(6):3498-3504. doi: 10.1021/acs.nanolett.9b00321. Epub 2019 May 09. PMID: 31039317.
Copy Download .nbib Format: NLM
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance.

bioRxiv : the preprint server for biology

Freeman B, Lester S, Mills L, Rasheed MAU, Moye S, Abiona O, Hutchinson GB, Morales-Betoulle M, Krapinunaya I, Gibbons A, Chiang CF, Cannon D, Klena J, Johnson JA, Owen SM, Graham BS, Corbett KS, Thornburg NJ.
PMID: 32511332
bioRxiv. 2020 Apr 25; doi: 10.1101/2020.04.24.057323.

Since emergence of SARS-CoV-2 in late 2019, there has been a critical need to understand prevalence, transmission patterns, to calculate the burden of disease and case fatality rates. Molecular diagnostics, the gold standard for identifying viremic cases, are not...

Cite
Freeman B, Lester S, Mills L, et al. Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. bioRxiv. 2020;doi: 10.1101/2020.04.24.057323.
Freeman, B., Lester, S., Mills, L., Rasheed, M. A. U., Moye, S., Abiona, O., Hutchinson, G. B., Morales-Betoulle, M., Krapinunaya, I., Gibbons, A., Chiang, C. F., Cannon, D., Klena, J., Johnson, J. A., Owen, S. M., Graham, B. S., Corbett, K. S., & Thornburg, N. J. (2020). Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.04.24.057323
Freeman, Brandi, et al. "Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.04.24.057323
Freeman B, Lester S, Mills L, Rasheed MAU, Moye S, Abiona O, Hutchinson GB, Morales-Betoulle M, Krapinunaya I, Gibbons A, Chiang CF, Cannon D, Klena J, Johnson JA, Owen SM, Graham BS, Corbett KS, Thornburg NJ. Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. bioRxiv. 2020 Apr 25; doi: 10.1101/2020.04.24.057323. PMID: 32511332; PMCID: PMC7239067.
Copy Download .nbib Format: NLM
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.

The Journal of infectious diseases

Shragai T, Smith-Jeffcoat SE, Koh M, Schechter MC, Rebolledo PA, Kasinathan V, Wang Y, Hoffman A, Miller H, Tejada-Strop A, Jain S, Tamin A, Harcourt JL, Thornburg NJ, Wong P, Medrzycki M, Folster JM, Semenova V, Steward-Clark E, Drobenuic J, Biedron C, Stewart RJ, da Silva J, Kirking HL, Tate JE.
PMID: 34216468
J Infect Dis. 2022 Jan 18;225(2):229-237. doi: 10.1093/infdis/jiab349.

BACKGROUND: The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse-transcription polymerase chain reaction (RT-PCR) testing.METHODS: Nasopharyngeal swabs and serum were collected at a single...

Cite
Shragai T, Smith-Jeffcoat SE, Koh M, et al. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing. J Infect Dis. 2022;225(2):229-237doi: 10.1093/infdis/jiab349.
Shragai, T., Smith-Jeffcoat, S. E., Koh, M., Schechter, M. C., Rebolledo, P. A., Kasinathan, V., Wang, Y., Hoffman, A., Miller, H., Tejada-Strop, A., Jain, S., Tamin, A., Harcourt, J. L., Thornburg, N. J., Wong, P., Medrzycki, M., Folster, J. M., Semenova, V., Steward-Clark, E., Drobenuic, J., Biedron, C., Stewart, R. J., da Silva, J., Kirking, H. L., Tate, J. E. (2022). Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing. The Journal of infectious diseases, 225(2), 229-237. https://doi.org/10.1093/infdis/jiab349
Shragai, Talya, et al. "Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing." The Journal of infectious diseases vol. 225,2 (2022): 229-237. doi: https://doi.org/10.1093/infdis/jiab349
Shragai T, Smith-Jeffcoat SE, Koh M, Schechter MC, Rebolledo PA, Kasinathan V, Wang Y, Hoffman A, Miller H, Tejada-Strop A, Jain S, Tamin A, Harcourt JL, Thornburg NJ, Wong P, Medrzycki M, Folster JM, Semenova V, Steward-Clark E, Drobenuic J, Biedron C, Stewart RJ, da Silva J, Kirking HL, Tate JE. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing. J Infect Dis. 2022 Jan 18;225(2):229-237. doi: 10.1093/infdis/jiab349. PMID: 34216468.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 80 entries